Ancora Advisors LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ancora Advisors LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,008
-95.6%
14
-90.7%
0.00%
-100.0%
Q1 2021$23,000
+53.3%
1500.0%0.00%
Q4 2020$15,000
+7.1%
1500.0%0.00%
-100.0%
Q3 2020$14,000
-17.6%
1500.0%0.00%0.0%
Q2 2020$17,000
+54.5%
1500.0%0.00%0.0%
Q1 2020$11,000
-31.2%
1500.0%0.00%0.0%
Q4 2019$16,000
-61.0%
1500.0%0.00%
-50.0%
Q3 2018$41,000
+173.3%
1500.0%0.00%
+100.0%
Q4 2016$15,0001500.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders